NovAccess Global Closes its Redemption Transaction and expands the Executive Board

NovAccess Global, Inc.’s CEO to attend BIO Conference in New York

NovAccess Global, Inc. Names Neil Laird, Chief Financial Officer

NovAccess Global, Inc. Expands Advisory Board

NovAccess Global, Inc. to Present at the Prestigious Society for Brain Mapping and Therapeutics 2021 World Congress

NovAccess Global, Inc. Announces Successful Completion of Pre-IND Meeting with FDA

NovAccess Global Readies for Development of Novel Immunotherapies for Brain Tumor Patients with pre-IND meeting scheduled with the FDA and Files Form 10-K for Fiscal 2020 and Form 10-Q for FQ1/FQ2, 2021
NovAccess Global Secures Worldwide Rights to Approved Patent
